Emerging respiratory disease outbreaks pose a major threat to food production systems. Agricultural workers live in larger, more crowded households than the general population, amplifying their potential exposure to respiratory pathogens, yet the consequences for worker health and food production remain poorly understood. We developed a household-structured susceptible-infectious-recovered (SIR) transmission model to compare disease dynamics between agricultural workers and the general U.S. population across six regions. We simulated outbreaks across a range of epidemiological scenarios and assessed productivity losses in California for three labor-intensive crops (oranges, iceberg lettuce, strawberries) with different harvest seasonalities. For a baseline reproduction number of ℛ0 = 1.5, peak disease prevalence among agricultural workers was 1.23-1.45 times higher than that of the general population across regions, and final outbreak sizes were 1.15-1.28 times higher. Peak productivity losses ranged from 0.50%-0.62% across crops, translating to millions in lost revenue. At higher transmissibility and severity (ℛ0 = 3 and assuming all infections are symptomatic), losses were over 2.5 times higher. Household crowding may lead to disproportionate respiratory disease burden among agricultural workers, highlighting the need for targeted outbreak preparedness and mitigation strategies in the agricultural sector to maintain food system resilience and support public health in these communities.

The authors have declared no competing interest.

This work was supported in part by the Interdisciplinary Quantitative Biology (IQ Biology) PhD program at the BioFrontiers Institute, University of Colorado Boulder, and the National Science Foundation NRT Integrated Data Science Fellowship (award 2022138).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes